Cargando…

Valproic Acid Prodrug Affects Selective Markers, Augments Doxorubicin Anticancer Activity and Attenuates Its Toxicity in a Murine Model of Aggressive Breast Cancer

We studied the unique inhibitor of the histone deacetylases (HDAC) valproate-valpromide of acyclovir (AN446) that upon metabolic degradation release the HDAC inhibitor (HDACI) valproic acid (VPA). Among the HDAC inhibitors that we have tested, only AN446, and to a lesser extent VPA, synergized with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tarasenko, Nataly, Wilner, Harel Josef, Nudelman, Abraham, Kessler-Icekson, Gania, Rephaeli, Ada
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706415/ https://www.ncbi.nlm.nih.gov/pubmed/34959644 http://dx.doi.org/10.3390/ph14121244

Ejemplares similares

Disparate Impact of Butyroyloxymethyl Diethylphosphate (AN-7), a Histone Deacetylase Inhibitor, and Doxorubicin in Mice Bearing a Mammary Tumor
por: Tarasenko, Nataly, et al.
Publicado: (2012)

Anticancer prodrugs of butyric acid and formaldehyde protect against doxorubicin-induced cardiotoxicity
por: Rephaeli, A, et al.
Publicado: (2007)

The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with Doxorubicin
por: Moyal, Lilach, et al.
Publicado: (2016)

The Histone Deacetylase Inhibitor AN7, Attenuates Choroidal Neovascularization in a Mouse Model
por: Dahbash, Mor, et al.
Publicado: (2019)

PEGylated Doxorubicin Prodrug-Forming Reduction-Sensitive Micelles With High Drug Loading and Improved Anticancer Therapy
por: Wang, Dongdong, et al.
Publicado: (2021)

The Transition from Gastric Intestinal Metaplasia to Gastric Cancer Involves POPDC1 and POPDC3 Downregulation
por: Gingold-Belfer, Rachel, et al.
Publicado: (2021)

Comparison of Anticancer Effects of Carbamazepine and Valproic Acid
por: Akbarzadeh, Ladan, et al.
Publicado: (2016)

Vasoactive Intestinal Peptide and Its Receptors in Human Ovarian Cortical Follicles
por: Gabbay-Benziv, Rinat, et al.
Publicado: (2012)

Effects of Valproic Acid on Radiation-Induced Chromosomal Aberrations in Human Lymphocytes
por: Di Tomaso, María Vittoria, et al.
Publicado: (2017)

Schiff-Linked PEGylated Doxorubicin Prodrug Forming pH-Responsive Nanoparticles With High Drug Loading and Effective Anticancer Therapy
por: Song, Jian, et al.
Publicado: (2021)

Structure-based design of anticancer prodrug PABA/NO
por: Ji, Xinhua, et al.
Publicado: (2009)

Cathepsin B-cleavable doxorubicin prodrugs for targeted cancer therapy
por: ZHONG, YAN-JUN, et al.
Publicado: (2012)

Combination treatment with doxorubicin and gamitrinib synergistically augments anticancer activity through enhanced activation of Bim
por: Park, Hye-Kyung, et al.
Publicado: (2014)

Ligand Evolution in the Photoactivatable Platinum(IV) Anticancer Prodrugs
por: Huang, Jingjing, et al.
Publicado: (2022)

A Novel Doxorubicin Prodrug with Controllable Photolysis Activation for Cancer Chemotherapy
por: Ibsen, Stuart, et al.
Publicado: (2010)

Spatiotemporal Control of Doxorubicin Delivery from “Stealth-Like” Prodrug Micelles
por: Kong, Li, et al.
Publicado: (2017)

Enhanced Cellular Uptake and Pharmacokinetic Characteristics of Doxorubicin-Valine Amide Prodrug
por: Park, Yohan, et al.
Publicado: (2016)

Remote loading paclitaxel–doxorubicin prodrug into liposomes for cancer combination therapy
por: Yu, Jiang, et al.
Publicado: (2020)

An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo
por: Mayr, Josef, et al.
Publicado: (2017)

Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity
por: Khoury, Aleen, et al.
Publicado: (2022)

Popeye Domain Containing 1 (Popdc1/Bves) Is a Caveolae-Associated Protein Involved in Ischemia Tolerance
por: Alcalay, Yifat, et al.
Publicado: (2013)

Cardiovascular Aggression by Doxorubicin: The Search for Mechanisms
por: Martins, Wolney de Andrade
Publicado: (2018)

Preclinical evaluation of the cardiac toxicity of HMR-1826, a novel prodrug of doxorubicin
por: Platel, D, et al.
Publicado: (1999)

Optimized 5-Fluorouridine Prodrug for Co-Loading with Doxorubicin in Clinically Relevant Liposomes
por: Wu, Debra, et al.
Publicado: (2021)

Microbial cytosine deaminase is a programmable anticancer prodrug mediating enzyme: antibody, and gene directed enzyme prodrug therapy
por: El-Sayed, Ashraf S.A., et al.
Publicado: (2022)

Combinatorial Effects of Thymoquinone on the Anticancer Activity and Hepatotoxicity of the Prodrug CB 1954
por: Talib, Wamidh H., et al.
Publicado: (2013)

Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosides
por: McGuigan, Christopher, et al.
Publicado: (2013)

Photoactivatable Cell-Selective Dinuclear trans-Diazidoplatinum(IV) Anticancer Prodrugs
por: Shi, Huayun, et al.
Publicado: (2018)

Tumor-targeted dual-action NSAID-platinum(iv) anticancer prodrugs
por: Kastner, Alexander, et al.
Publicado: (2023)

A Nanomicellar Prodrug Carrier Based on Ibuprofen-Conjugated Polymer for Co-delivery of Doxorubicin
por: Li, Zuojun, et al.
Publicado: (2018)

Simultaneous determination of doxorubicin and its dipeptide prodrug in mice plasma by HPLC with fluorescence detection()
por: Han, Jing, et al.
Publicado: (2016)

Lymph cancer chemotherapy: delivery of doxorubicin–gemcitabine prodrug and vincristine by nanostructured lipid carriers
por: Ni, Shuqin, et al.
Publicado: (2017)

Co-Delivery of Paclitaxel and Doxorubicin by pH-Responsive Prodrug Micelles for Cancer Therapy
por: Jiang, Yanhua, et al.
Publicado: (2020)

Ultrasound-directed enzyme-prodrug therapy (UDEPT) using self-immolative doxorubicin derivatives
por: Roemhild, Karolin, et al.
Publicado: (2022)

One-pot synthesis and enzyme-responsiveness of amphiphilic doxorubicin prodrug nanomicelles for cancer therapeutics
por: Han, Ling-Na, et al.
Publicado: (2022)

Synthesis and preliminary biological evaluation of gabactyzine, a benactyzine-GABA mutual prodrug, as an organophosphate antidote
por: Weitman, Michal, et al.
Publicado: (2022)

Anticancer efficacy of the hypoxia‐activated prodrug evofosfamide (TH‐302) in osteolytic breast cancer murine models
por: Liapis, Vasilios, et al.
Publicado: (2016)

Team Interdependence as a Substitute for Empowering Leadership Contribution to Team Meaningfulness and Performance
por: Lisak, Alon, et al.
Publicado: (2022)

Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity
por: Kciuk, Mateusz, et al.
Publicado: (2023)

Induction of targeted necrosis with HER2-targeted platinum(iv) anticancer prodrugs
por: Wong, Daniel Yuan Qiang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8h7ookgs7agb17qhbdeecivapp